A drug approved to treat obesity in adults and teens is safe and effective for use in kids as young as 6, when combined with ...

This undated photo provided by Novo Nordisk shows flags bearing the company's logo. A drug approved to treat obesity in adults and teens is safe and effective for use in kids as young as 6 when ...

This undated photo provided by Novo Nordisk shows flags bearing the company's logo. (Novo Nordisk via AP) A drug approved to treat obesity in adults and teens is safe and effective for use in kids as ...

Medical bottles and syringe are seen with Eli Lilly and Company logo displayed on a screen ... drugs has transformed Eli ...

Novo Nordisk's shares fell nearly 5% on Friday after results from a Phase 2a trial of the Danish drugmaker's experimental ...

Ozempic maker Novo Nordisk (NVO) announced mixed results today for a phase 2 trial of an experimental weight loss pill that ...

In a report released today, Jo Walton from UBS maintained a Hold rating on Novo Nordisk (0QIU – Research Report), with a price target of ...

Novo Nordisk said that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a ...

Novo Nordisk, tje manufacturer behind Ozempic and Wegovy has another weight loss medication in the works — but according to ...

Novo Nordisk's U.S.-listed shares lost ground Friday after a study of the pharmaceutical firm’s latest obesity treatment ...